What is the share price of Blue Jet Healthcare Ltd (BLUEJET) today?
The share price of BLUEJET as on 10th July 2025 is ₹917.15. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Blue Jet Healthcare Ltd (BLUEJET) share?
The past returns of Blue Jet Healthcare Ltd (BLUEJET) share are- Past 1 week: 8.32%
- Past 1 month: 2.24%
- Past 3 months: 46.50%
- Past 6 months: 60.48%
- Past 1 year: 115.34%
- Past 3 years: N/A%
- Past 5 years: 121.86%
What are the peers or stocks similar to Blue Jet Healthcare Ltd (BLUEJET)?
The peers or stocks similar to Blue Jet Healthcare Ltd (BLUEJET) include:What is the market cap of Blue Jet Healthcare Ltd (BLUEJET) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Blue Jet Healthcare Ltd (BLUEJET) is ₹15817.44 Cr as of 10th July 2025.What is the 52 week high and low of Blue Jet Healthcare Ltd (BLUEJET) share?
The 52-week high of Blue Jet Healthcare Ltd (BLUEJET) is ₹986 and the 52-week low is ₹400.What is the PE and PB ratio of Blue Jet Healthcare Ltd (BLUEJET) stock?
The P/E (price-to-earnings) ratio of Blue Jet Healthcare Ltd (BLUEJET) is 51.83. The P/B (price-to-book) ratio is 18.71.Which sector does Blue Jet Healthcare Ltd (BLUEJET) belong to?
Blue Jet Healthcare Ltd (BLUEJET) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Blue Jet Healthcare Ltd (BLUEJET) shares?
You can directly buy Blue Jet Healthcare Ltd (BLUEJET) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Blue Jet Healthcare Ltd
BLUEJET Share Price
917.150.58% (+5.30)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
BLUEJET Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
BLUEJET Performance & Key Metrics
BLUEJET Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 51.83 | 18.71 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.77 | 6.43 | 0.79% |
67%
Analysts have suggested that investors can buy this stock
from 6 analysts
Price Upside
Earnings Growth
Rev. Growth
BLUEJET Company Profile
Blue Jet Healthcare is an India-based specialty pharmaceutical and healthcare ingredients and intermediates company.
SUNPHARMA
PE Ratio
36.65
36.65
1Y Return
4.00%
4.00%
Buy Reco %
87.50
87.50
CIPLA
PE Ratio
22.85
22.85
1Y Return
2.34%
2.34%
Buy Reco %
73.33
73.33
TORNTPHARM
PE Ratio
59.39
59.39
1Y Return
13.13%
13.13%
Buy Reco %
70.83
70.83
DRREDDY
PE Ratio
18.68
18.68
1Y Return
4.24%
4.24%
Buy Reco %
51.72
51.72
MANKIND
PE Ratio
52.37
52.37
1Y Return
18.31%
18.31%
Buy Reco %
81.25
81.25
BLUEJET Sentiment Analysis
BLUEJET Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
BLUEJET Stock Summary · May 2025
In FY'25, the company achieved record revenue and profit, driven by a remarkable surge in the pharma intermediates and API segment, despite facing challenges in the contrast media sector due to demand fluctuations. Investments in capacity expansion and sustainability initiatives, including a new multipurpose plant and R&D center, position the company for future growth, particularly in high-demand markets. While operational efficiency has improved, with stable margins and a strategic shift in product mix, the management remains cautious about potential market saturation in certain segments. Optimism surrounds the rollout of new products and the anticipated recovery in the contrast media market, supported by strong client demand and a favorable competitive landscape. Overall, the company is well-prepared to capitalize on emerging opportunities while maintaining a focus on operational readiness and compliance.
BLUEJET Stock Growth Drivers
BLUEJET Stock Growth Drivers
6Record Financial Performance
Blue Jet Healthcare Limited achieved a record-setting financial performance in FY'25, with total revenue of
Operational Capacity Expansion
The company has made substantial investments in operational capacity, adding 157 KL of new capacity
BLUEJET Stock Challenges
BLUEJET Stock Challenges
0
Hmm, looks like there are nochallenges
BLUEJET Forecast
BLUEJET Forecasts
Price
Revenue
Earnings
BLUEJET Share Price Forecast
BLUEJET Share Price Forecast
2025
Current
₹917.15
Baseline
Forecast for Jul 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹917.15
Baseline
Forecast for Jul 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
BLUEJET Company Revenue Forecast
BLUEJET Company Revenue Forecast
2025
Current
₹1.08
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹1.08
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
BLUEJET Stock EPS (Earnings Per Share) Forecast
BLUEJET Stock EPS (Earnings Per Share) Forecast
2025
Current
₹17.59
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹17.59
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
BLUEJET
BLUEJET
Income
Balance Sheet
Cash Flow
Annual Normal View
BLUEJET Income Statement
BLUEJET Income Statement
Annual Normal View
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 543.92 | 507.54 | 702.88 | 744.94 | 740.46 | 1,076.24 | 1,076.23 | |||||||
Raw Materials | 186.76 | 214.27 | 283.65 | 350.29 | 304.27 | 652.26 | 652.26 | |||||||
| Power & Fuel Cost | 19.30 | 19.91 | 27.25 | 32.99 | 24.56 | |||||||||
| Employee Cost | 23.88 | 28.96 | 33.03 | 41.90 | 53.19 | |||||||||
| Selling & Administrative Expenses | 34.40 | 31.91 | 43.06 | 39.75 | 33.50 | |||||||||
| Operating & Other expenses | 60.29 | -2.96 | 47.21 | 36.96 | 76.59 | |||||||||
EBITDA | 219.29 | 215.45 | 268.68 | 243.05 | 248.35 | 423.98 | 423.97 | |||||||
| Depreciation/Amortization | 18.04 | 19.67 | 22.15 | 25.07 | 28.09 | 17.79 | 17.80 | |||||||
| PBIT | 201.25 | 195.78 | 246.53 | 217.98 | 220.26 | 406.19 | 406.17 | |||||||
| Interest & Other Items | 7.37 | 5.31 | 3.30 | 1.36 | 0.16 | 0.10 | 0.10 | |||||||
| PBT | 193.88 | 190.47 | 243.23 | 216.62 | 220.10 | 406.09 | 406.07 | |||||||
| Taxes & Other Items | 49.17 | 48.87 | 61.64 | 56.58 | 56.34 | 100.90 | 100.90 | |||||||
| Net Income | 144.71 | 141.60 | 181.59 | 160.04 | 163.76 | 305.19 | 305.17 | |||||||
| EPS | 137.82 | 15.39 | 10.47 | 9.23 | 9.44 | 17.59 | 17.59 | |||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 1.00 | |||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.00 | 0.06 |
BLUEJET Company Updates
FY 2025FY 2025
Investor Presentation
May 14PDF
Jan 29PDF
Nov 4PDF
Oct 30PDF
BLUEJET Stock Peers
BLUEJET Past Performance & Peer Comparison
BLUEJET Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation-basic on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Blue Jet Healthcare Ltd | 51.83 | 18.71 | — |
| Sun Pharmaceutical Industries Ltd | 36.65 | 5.53 | 0.96% |
| Cipla Ltd | 22.85 | 3.85 | 1.07% |
| Torrent Pharmaceuticals Ltd | 59.39 | 14.95 | 0.18% |
BLUEJET Stock Price Comparison
Compare BLUEJET with any stock or ETFCompare BLUEJET with any stock or ETF
BLUEJET
BLUEJET Holdings
BLUEJET Shareholdings
BLUEJET Promoter Holdings Trend
BLUEJET Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
BLUEJET Institutional Holdings Trend
BLUEJET Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 1.18%
Increased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has increased by 1.18%
BLUEJET Shareholding Pattern
BLUEJET Shareholding Pattern
BLUEJET Shareholding History
BLUEJET Shareholding History
Foreign Institutions
Mutual Funds Invested in BLUEJET
Mutual Funds Invested in BLUEJET
No mutual funds holding trends are available
Top 5 Mutual Funds holding Blue Jet Healthcare Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.2809% | Percentage of the fund’s portfolio invested in the stock 0.92% | Change in the portfolio weight of the stock over the last 3 months -0.16% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 74/97 (-4) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1131% | Percentage of the fund’s portfolio invested in the stock 1.74% | Change in the portfolio weight of the stock over the last 3 months -0.62% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 46/85 (-2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0434% | Percentage of the fund’s portfolio invested in the stock 0.27% | Change in the portfolio weight of the stock over the last 3 months -0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 158/255 (-27) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing BLUEJET stock
smallcases containing BLUEJET stock
Looks like this stock is not in any smallcase yet.
BLUEJET Events
BLUEJET Events
BLUEJET Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
BLUEJET Dividend Trend
No dividend trend available
BLUEJET Upcoming Dividends
BLUEJET Upcoming Dividends
No upcoming dividends are available
BLUEJET Past Dividends
BLUEJET Past Dividends
Cash Dividend
Ex DateEx DateSep 17, 2024
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Sep 17, 2024
BLUEJET Stock News & Opinions
BLUEJET Stock News & Opinions
Articles & Videos
Earnings
Blue Jet Healthcare standalone net profit rises 177.68% in the March 2025 quarter
Net profit of Blue Jet Healthcare rose 177.68% to Rs 110.10 crore in the quarter ended March 2025 as against Rs 39.65 crore during the previous quarter ended March 2024. Sales rose 85.08% to Rs 340.45 crore in the quarter ended March 2025 as against Rs 183.95 crore during the previous quarter ended March 2024. For the full year,net profit rose 86.38% to Rs 305.20 crore in the year ended March 2025 as against Rs 163.75 crore during the previous year ended March 2024. Sales rose 44.74% to Rs 1029.99 crore in the year ended March 2025 as against Rs 711.60 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales340.45183.95 85 1029.99711.60 45 OPM %41.1128.85 -36.6732.21 - PBDT152.1761.87 146 423.89257.92 64 PBT147.2254.15 172 406.10229.83 77 NP110.1039.65 178 305.20163.75 86 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Blue Jet Healthcare recommends Final Dividend
Blue Jet Healthcare announced that the Board of Directors of the Company at its meeting held on 14 May 2025, has recommended a Final Dividend of Rs.1.20 per share (i.e.60%), subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Blue Jet Healthcare to conduct board meeting
Blue Jet Healthcare will hold a meeting of the Board of Directors of the Company on 14 May 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Spotlight
Blue Jet Healthcare jumps after broker initiates 'buy' rating
The broker cited a favourable outlook supported by the company's ability to scale up high-margin products and secure more long-term contracts, which could potentially enhance both growth and valuations. The brokerage noted that Blue Jet's advanced research and development capabilities, along with its backward integration and expertise in complex chemistries, position it well to serve both regulated and emerging markets. These factors, it said, place the company at the forefront of delivering high-value pharma solutions. Looking ahead, the brokerage expects Blue Jet's revenue growth to be fueled by its pipeline of new products in iodinated and gadolinium contrast media, novel chemical entity (NCE) intermediates, and innovations in high-intensity sweeteners. Blue Jet Healthcare is a specialty pharmaceutical and healthcare ingredient and intermediate company, operating under a contract development and manufacturing organization (CDMO) business model. The company has specialized chemistry capabilities in contrast media intermediates and high-intensity sweeteners. On a standalone basis, net profit of Blue Jet Healthcare soared 208.25% to Rs 98.98 crore while net sales climbed 90.92% to Rs 318.38 crore in Q3 December 2024 over Q3 December 2023. Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Blue Jet Healthcare standalone net profit rises 208.25% in the December 2024 quarter
Net profit of Blue Jet Healthcare rose 208.25% to Rs 98.98 crore in the quarter ended December 2024 as against Rs 32.11 crore during the previous quarter ended December 2023. Sales rose 90.92% to Rs 318.38 crore in the quarter ended December 2024 as against Rs 166.76 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales318.38166.76 91 OPM %38.9532.74 - PBDT137.2461.30 124 PBT132.4953.44 148 NP98.9832.11 208 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Blue Jet Healthcare to table results
Blue Jet Healthcare will hold a meeting of the Board of Directors of the Company on 29 January 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Blue Jet Healthcare standalone net profit rises 21.89% in the September 2024 quarter
Net profit of Blue Jet Healthcare rose 21.89% to Rs 58.35 crore in the quarter ended September 2024 as against Rs 47.87 crore during the previous quarter ended September 2023. Sales rose 14.84% to Rs 208.26 crore in the quarter ended September 2024 as against Rs 181.35 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales208.26181.35 15 OPM %33.3734.54 - PBDT81.5570.80 15 PBT76.9364.33 20 NP58.3547.87 22 Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Blue Jet Healthcare to convene AGM
Blue Jet Healthcare announced that the 56th Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Earnings
Blue Jet Healthcare standalone net profit declines 14.37% in the June 2024 quarter
Net profit of Blue Jet Healthcare declined 14.37% to Rs 37.78 crore in the quarter ended June 2024 as against Rs 44.12 crore during the previous quarter ended June 2023. Sales declined 9.27% to Rs 162.90 crore in the quarter ended June 2024 as against Rs 179.54 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales162.90179.54 -9 OPM %27.1732.84 - PBDT52.9563.97 -17 PBT49.4757.92 -15 NP37.7844.12 -14 Powered by Capital Market - Live
11 months agoCapital Market - Live
Corporate
Blue Jet Healthcare to hold board meeting
Blue Jet Healthcare will hold a meeting of the Board of Directors of the Company on 6 August 2024.Powered by Capital Market - Live
11 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 14.62%, vs industry avg of 10.1%
Over the last 5 years, market share increased from 0.22% to 0.26%
Over the last 5 years, net income has grown at a yearly rate of 16.1%, vs industry avg of 20.04%